Residency · Residency · Emergency Medicine
First Trimester Bleeding and Miscarriage Management
Introduction
First trimester vaginal bleeding is one of the most common obstetric complaints in the emergency department, affecting approximately 25 percent of all pregnancies. While many cases represent benign etiologies, the emergency physician must systematically evaluate for life-threatening diagnoses -- particularly ectopic pregnancy -- and provide compassionate, evidence-based management for patients experiencing pregnancy loss. Approximately 15 to 25 percent of clinically recognized pregnancies end in miscarriage, making this one of the most emotionally and medically significant encounters in emergency medicine.
Differential Diagnosis of First Trimester Bleeding
Life-Threatening Causes
Ectopic pregnancy must be excluded in every patient with first trimester bleeding, occurring in 1 to 2 percent of all pregnancies (see Lecture 56 for detailed management). Ruptured ectopic pregnancy presents with hemorrhagic shock and peritoneal signs and is a surgical emergency. Gestational trophoblastic disease (molar pregnancy) presents with vaginal bleeding, uterine size greater than expected for dates, markedly elevated beta-hCG (often above 100,000 mIU/mL), and a "snowstorm" ultrasound appearance, with risk of malignant transformation.
Common Causes
| Type | Cervical Os | Bleeding | Tissue Passed | Ultrasound Finding |
|---|---|---|---|---|
| Threatened | Closed | Present | No | Viable IUP with cardiac activity |
| Inevitable | Open | Present | Not yet | Gestational sac intact or bulging through os |
| Incomplete | Open | Heavy | Partial | Retained products (heterogeneous endometrial contents) |
| Complete | Closed | Resolving | Complete | Empty uterus, thin endometrium |
| Missed | Closed | None/minimal | No | Nonviable IUP (no cardiac activity; CRL ≥ 7 mm or empty sac ≥ 25 mm) |
Threatened miscarriage refers to vaginal bleeding with a closed cervical os and viable intrauterine pregnancy. Inevitable miscarriage involves vaginal bleeding with an open cervical os, indicating that pregnancy loss is imminent. Incomplete miscarriage is the partial passage of products of conception with an open os and retained tissue. Complete miscarriage is the complete passage of all products of conception with a closed os and empty uterus. Missed miscarriage (missed abortion) describes a nonviable pregnancy with absent fetal cardiac activity or empty gestational sac without bleeding or passage of tissue, diagnosed incidentally on ultrasound. Subchorionic hemorrhage is bleeding between the chorion and the uterine wall, appearing as a crescent-shaped collection on ultrasound, with most resolving spontaneously.
Other Causes
Additional causes include cervical pathology (cervical ectropion, polyps, cervicitis, cervical cancer), vaginal or vulvar trauma, post-coital bleeding, and implantation bleeding (typically light spotting around the time of expected menses).
Initial Assessment
History
Key history elements include the last menstrual period and estimated gestational age, the amount, duration, and character of bleeding (number of pads, passage of tissue or clots), associated symptoms such as cramping, fever, lightheadedness, and shoulder pain, prior pregnancies, prior miscarriages, prior ectopic pregnancy, fertility treatments (which increase heterotopic pregnancy risk), and Rh status if known.
Physical Examination
Vital signs should be assessed for hemodynamic instability including tachycardia and hypotension. The abdominal examination evaluates for tenderness, peritoneal signs, and uterine size. The speculum examination identifies the source of bleeding (cervical versus uterine), assesses whether the cervical os is open or closed, and looks for visible products of conception in the os, which should be removed with ring forceps as this may immediately reduce bleeding and cramping. The bimanual examination assesses uterine size, tenderness, and adnexal masses or tenderness.
Laboratory Studies
A quantitative beta-hCG is essential for correlating with ultrasound findings. Type and screen with Rh status determination is critical for deciding whether Rh immunoglobulin is needed. A CBC assesses for anemia if significant bleeding is present. A comprehensive metabolic panel is obtained if clinically indicated.
<image>Speculum examination findings in different types of miscarriage: threatened miscarriage with closed external os and minimal blood in the vaginal vault, inevitable miscarriage with dilated os and blood at the cervix, and incomplete miscarriage with tissue visible in the open cervical os, each with labeled anatomical landmarks</image>
Ultrasound Evaluation
Diagnostic Criteria for Pregnancy Failure (ACOG/Society of Radiologists in Ultrasound)
Definitive findings of a nonviable pregnancy include a crown-rump length of 7 mm or greater with no cardiac activity, or a mean gestational sac diameter of 25 mm or greater with no embryo (anembryonic pregnancy or blighted ovum). Suspicious but not diagnostic findings that require repeat ultrasound in 7 to 14 days include a CRL less than 7 mm with no cardiac activity, a mean sac diameter of 16 to 24 mm with no embryo, absent embryonic heartbeat 14 or more days after a scan showing a gestational sac without a yolk sac, and absent embryonic heartbeat 11 or more days after a scan showing a gestational sac with a yolk sac. A viable intrauterine pregnancy is confirmed by an intrauterine gestational sac with visible fetal cardiac activity.
Pregnancy of Unknown Location (PUL)
A pregnancy of unknown location describes a positive beta-hCG with no intrauterine pregnancy or ectopic visualized on ultrasound. If the beta-hCG is below the discriminatory zone (1,500 to 3,000 mIU/mL), this may represent a very early viable intrauterine pregnancy, early ectopic, or completed miscarriage. Serial beta-hCG monitoring at 48-hour intervals guides management: a normal rise of 35 percent or more in 48 hours suggests a likely early viable IUP warranting repeat ultrasound when above the discriminatory zone, an abnormal rise or plateau suggests possible ectopic or nonviable IUP, and declining levels suggest possible completed miscarriage or resolving ectopic.
Management of Miscarriage
Threatened Miscarriage
Threatened miscarriage involves a viable IUP with vaginal bleeding and a closed cervical os. Fifty percent of threatened miscarriages progress to pregnancy loss, while the other half result in normal pregnancy outcomes. Management is expectant, with pelvic rest (avoiding intercourse, tampons, and douching) and return precautions for heavy bleeding, severe pain, fever, or passage of tissue. Obstetric follow-up should occur within 48 to 72 hours with repeat ultrasound.
Management Options for Confirmed Nonviable Pregnancy
Expectant management allows natural expulsion of pregnancy tissue and is successful in 80 percent of incomplete miscarriages within 2 to 4 weeks, though it is less effective for missed miscarriages (50 to 60 percent success). The patient must have reliable follow-up and accept the potential for unpredictable heavy bleeding. Medical management with misoprostol 800 mcg vaginally (the most effective route), with or without mifepristone 200 mg orally 24 hours prior, achieves 80 to 90 percent complete expulsion within 1 to 2 weeks, with common side effects including cramping, bleeding, diarrhea, and nausea. Surgical management with uterine aspiration, either manual vacuum aspiration (MVA) or suction curettage, is 95 to 100 percent effective and is indicated for hemodynamic instability, heavy bleeding, signs of infection, or patient preference. MVA can be performed in the ED.
Hemodynamically Unstable Patients
Management includes aggressive IV fluid resuscitation and blood transfusion as needed, removal of any tissue visible in the cervical os with ring forceps, and emergent uterine aspiration or operating room D&C. Uterotonic agents are used if heavy bleeding persists: methylergonovine (Methergine) 0.2 mg IM, misoprostol 800 to 1000 mcg rectally, or oxytocin 20 to 40 units in 1 liter of normal saline IV infusion. OB/GYN should be consulted emergently.
Rh Immunoglobulin Administration
All Rh-negative patients with first trimester bleeding should receive Rh immunoglobulin (RhoGAM) to prevent Rh alloimmunization. The first trimester dose of 50 mcg (micro-dose) IM is sufficient for pregnancies before 12 weeks, though 300 mcg (standard dose) is commonly used and is always appropriate. It should be administered within 72 hours of the bleeding event.
Septic Miscarriage
Septic miscarriage is infection of retained products of conception, presenting with fever, uterine tenderness, foul-smelling discharge, and hemodynamic instability. It is associated with incomplete miscarriage, retained products, and unsafe abortion practices. Treatment requires broad-spectrum IV antibiotics (clindamycin plus gentamicin, or ampicillin plus gentamicin plus metronidazole) followed by emergent uterine evacuation after antibiotic initiation. Septic miscarriage can progress rapidly to septic shock and multi-organ failure.
<image>Transvaginal ultrasound images comparing a viable early intrauterine pregnancy with visible yolk sac and fetal pole with cardiac activity (left), an anembryonic pregnancy showing a large empty gestational sac with no embryo (center), and an incomplete miscarriage with heterogeneous echogenic material within the endometrial cavity representing retained products of conception (right), with measurements and annotations</image>
Patient Communication and Support
Pregnancy loss is a deeply personal experience that requires compassionate, empathetic communication. Minimizing language such as "at least it was early" should be avoided, and the loss should be acknowledged directly. Patients should be reassured that miscarriage is common and rarely caused by their actions. The three management options (expectant, medical, surgical) should be discussed with the patient involved in shared decision-making. Written discharge instructions with specific return precautions should be provided: heavy bleeding (soaking more than 1 pad per hour for more than 2 hours), fever above 38 degrees Celsius, severe abdominal pain, and dizziness or fainting. Obstetric follow-up within 1 to 2 weeks should be arranged, and mental health resources and grief support should be offered as appropriate.
Clinical Pearls
Ectopic pregnancy must be excluded in every patient with first trimester bleeding before attributing symptoms to miscarriage. A single beta-hCG value cannot distinguish between viable IUP, ectopic, and nonviable pregnancy; serial monitoring and ultrasound correlation are essential. Tissue visible in the cervical os should be removed with ring forceps, as this often significantly reduces bleeding and pain. Rh immunoglobulin should be administered to all Rh-negative patients with first trimester bleeding. The three management options for confirmed miscarriage (expectant, medical, surgical) have equivalent long-term outcomes, and patient preference should guide the decision.
References
- Doubilet PM, Benson CB, Bourne T, et al. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med. 2013;369(15):1443-1451.
- ACOG Practice Bulletin No. 200: Early pregnancy loss. Obstet Gynecol. 2018;132(5):e197-e207.
- Nanda K, Lopez LM, Grimes DA, et al. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev. 2012;(3):CD003518.
- Schreiber CA, Creinin MD, Atrio J, et al. Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med. 2018;378(23):2161-2170.
